The problem with bioplastics is that they are not supposed to end up in a landfill, but they often do. They are designed to be composted, but most municipal organic waste facilities are not designed to handle them. They create a clog in the circular economy, a well-intentioned material that becomes a headache for waste operators. Urobo Biotech, a spinout from Stellenbosch University and the University of Padova, is betting that the solution is not better sorting, but better bugs.
Founded in 2023 by a team of PhD researchers, the company is developing enzymatic and microbial processes to break down bioplastics directly in mixed waste streams, converting them into chemicals and fuels. The pitch is simple: give waste management companies a way to turn a nuisance into a revenue stream, and boost biogas production in their anaerobic digesters in the process [SARECO, Unknown] [urobobiotech.com, Unknown].
A wedge in the waste stream
Urobo’s technology targets a specific, growing pain point. As bioplastics like PLA (polylactic acid) become more common in packaging, they increasingly contaminate both recycling and organic waste streams. Sorting them out is expensive and imperfect. The company’s proposed enzymes are designed to be selective, breaking down the bioplastics without harming the rest of the organic material. This means the technology could be dropped into existing anaerobic digestion facilities, the large, sealed tanks where organic waste is broken down to produce methane for energy. By converting the stubborn bioplastic fraction into more readily digestible compounds, Urobo claims it can increase a facility’s overall biogas yield [urobobiotech.com, Unknown]. The primary buyer, then, is the waste management operator looking to improve the economics of their organic processing plant.
Validation from the pitch circuit
While the company has not disclosed commercial deployments or funding details, its academic roots and competition wins provide early validation signals. The founding team is deeply embedded in the science, with CEO Wessel Myburgh and COO Dominique Rocher both completing co-tutelage PhDs between Stellenbosch and Padova, focused on enzymatic plastic degradation [innovus.co.za, Unknown]. They have turned that research into a compelling narrative for judges.
- Prize momentum. Urobo was the first South African team to reach the finals of the global Hult Prize startup competition, selected from over 188,000 applicants [unipd.it, Unknown].
- Local recognition. The team won the R100,000 (approx. $5,300) grand prize at the 2026 SWEAT Africa pitch competition [Stellenbosch University, Unknown].
- Early backing. They have participated in incubators like SARECO and the Hult Prize Digital Incubator, and secured a R20,000 prize from the Hult Prize South Africa showcase in 2025 [SARECO, 2024] [timeslive.co.za, 2025].
These wins suggest the team can articulate a complex biotech proposition to non-specialist audiences, a useful skill for future fundraising and customer conversations.
The incumbent to beat
The most direct counter-bet to Urobo’s approach is not another startup, but the status quo: landfilling. For a waste operator, the cheapest option for dealing with problematic bioplastic-contaminated organics is often to send it all to the dump. Urobo must prove its enzymatic treatment lowers the net cost of handling this stream, either by increasing energy sales enough to cover its fee or by avoiding future regulatory penalties for contamination. The unit economics hinge on the incremental biogas yield and the value of the chemicals produced.
A simple back-of-the-envelope calculation illustrates the scale. A mid-sized anaerobic digester might process 50,000 tons of organic waste annually. If bioplastics make up just 2% of that stream, that’s 1,000 tons of material. If Urobo’s process can convert that tonnage into additional biogas worth, say, $50 per ton more than the baseline, it creates a $50,000 annual value pool for that single facility. The company’s challenge is to capture a meaningful slice of that value while still making the math work for the operator.
The road from lab to lagoon
The leap from a prize-winning lab prototype to a product that works reliably in the messy, variable environment of an industrial waste lagoon is enormous. The next twelve months will be about moving from validation to verification. Key milestones to watch will be a disclosed pilot partnership with a waste management company, which would provide real-world data on performance and cost, and a formal funding round to scale the team beyond its academic founders. Without these, the company remains an intriguing research project. With them, Urobo Biotech could begin to prove that the most sensible end for a bioplastic is not a grave, but a catalyst.
Sources
- [SARECO, 2024] Urobo Biotech Profile | https://www.sareco.org/profile/urobo-biotech/
- [urobobiotech.com, Unknown] About Urobo Biotech | https://www.urobobiotech.com/about-urobo-biotech/
- [innovus.co.za, Unknown] Wessel and Dominique of Urobo Biotech Addresses Global Climate Challenges | https://innovus.co.za/wessel-and-dominique-of-urobo-biotech-addresses-global-climate-challenges/
- [unipd.it, Unknown] Urobo Biotech among top 22 startups of the Hult Prize | https://www.unipd.it/news/clone-urobo-biotech-top-22-start-dellhult-prize
- [Stellenbosch University, Unknown] SU biotech spin-out bags SWEAT Africa 2026 pitch prize | https://www.su.ac.za/en/news/su-biotech-spin-out-bags-sweat-africa-2026-pitch-prize
- [timeslive.co.za, 2025] Hult Prize SA National Showcase results | https://www.timeslive.co.za/news/south-africa/2025-03-10-hult-prize-sa-national-showcase-results-announced/